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Organs are complex structures that consist of multiple tissues with different levels of gene 
expression. To achieve a comprehensive coverage and accurate quantitation data, organs 
should ideally be separated into morphological and/or functional substructures prior to gene 
or protein expression analysis. However, due to complex morphology and elaborate isolation 
protocols, this was so far often difficult to achieve. Kidneys are organs where functional and 
morphological subdivision is especially important. Each subunit of the kidney, the nephron, 
itself consists of more than 10 subsegments with distinct morphological and functional 
characteristics. For a full understanding of kidney physiology, global gene and protein 
expression analyses have to be performed at the level of the nephron subsegments; however, 
such studies have so far been extremely rare. 
Here we describe the latest approaches in quantitative high accuracy mass spectrometry – 
based proteomics and their application to quantitative proteomics studies of the whole kidney 
and nephron subsegments, both in humans and in animal models. We compare these studies 
with similar studies performed on other organ substructures. We argue that the newest 
technologies used for preparation, processing and measurement of small amounts of starting 
material are finally enabling global and subsegment-specific quantitative measurement of 
protein levels in the kidney and other organs. These new technologies and approaches are 
making a decisive impact on our understanding of the (patho)physiological processes at the 
molecular level.   
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1. Introduction 
The kidneys are complex and morphologically heterogeneous organs consisting in 
humans of approximately one million nephrons. These nephrons produce urine by filtration of 
blood, reabsorption of water and substances, and parallel secretion of various metabolites and 
waste products. Several nephrons are drained into collecting ducts, the kidney pelvis, and 
ureters. The nephrons and collecting ducts can be subdivided into various segments based on 
functional and morphological criteria giving rise to at least 12 specific segments (glomerulus, 
S1, S2 and S3 segments of the proximal tubule, thin descending limb, thin ascending limb, 
thick ascending limb of the loop of Henle, early and late distal tubule, connecting tubule, 
cortical collecting duct, outer and inner medullary collecting ducts) (Figure 1). Further 
distinctions are possible based on the fact that some nephrons have their glomeruli in the 
superficial cortex and others closer to the cortico-medullary junction (juxtamedullary or deep 
nephrons), that some loops of Henle reach deep into the medulla, whereas other do not1. The 
kidneys are highly vascularized with about one liter of blood flow for filtration, nutrient and 
oxygen supply as well as transport of reabsorbed substrates.  Furthermore, various interstitial 
cell types such as immune cells, fibroblasts, or hormone producing cells contribute to the 
enormous morphological complexity of the kidney. 
This complexity has been examined in much detail on the morphological and 
functional level but much less on the molecular level. Doucet and colleagues have provided a 
first attempt to establish an overview over the transcripts expressed along the human nephron 
using SAGE technology and identified nearly 1000 transcripts2. However, in order to 
understand the function of the kidney, the mechanisms leading to kidney disease or to aid in 
the development of disease markers, a more detailed map of the mammalian kidney on the 
protein level is required.  
This review will focus on three areas of active research: 1) new developments in 
proteome technology allowing detection and quantitation of proteins in very small samples, 2) 
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novel methods enriching specific organ structures and cells using mouse lines expressing 
fluorescent proteins under organ- or cell specific promoters, and 3) application of these new 
developments to the kidney. Here we will mainly cover aspects relating to proteomics of solid 
organ structures; excellent reviews have recently described the state-of-the-art and challenges 
of urine proteomics3-5. 
 
2. Latest developments in MS-based proteomics 
Modern, gel-free and mass spectrometry (MS)-based quantitative proteomics is 
making a decisive impact across all life sciences and it is increasingly used in molecular 
physiology and anatomy. Relatively straightforward experiments based on high accuracy MS 
and powerful bioinformatics tools are capable of reliably identifying and quantifying 
expression levels of several thousand proteins per experiment, approaching the depth of 
message-based (RNA) assays and reaching the analytical capacity to completely map the 
smaller proteomes, such as that of yeast6. Likewise, recent progress in biochemical separation 
and enrichment protocols make it possible to detect dynamics of posttranslational 
modification sites upon a treatment, providing a wealth of information on signal transduction 
mechanisms that cannot be otherwise studied by genomics or transcriptomics7. Yet, the 
chemical diversity of protein sequences and limited accessibility of proteins in some tissues or 
sub-cellular structures still make a comprehensive proteome analysis a challenging task. In 
this chapter we will discuss recent developments in four major areas of a typical proteomics 
workflow: quantitative proteomics - specifically stable isotope labeling of proteins in cells 
and tissues, sample preparation, mass spectrometry measurement and data processing (Figure 
2). 
a. Tools for in-vivo quantitative proteomics 
Proteomics has long depended on 2D gels to quantify relative expression levels of 
proteins in a perturbed biological system8,9. While historically important, 2D gel approaches 
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have widely observed limitations (i.e. limited analyzed pI range, limited solubility of some 
classes of proteins and limited dynamic range of detection upon staining), which have 
necessitated the use of alternative approaches for protein quantitation. Today, modern 
proteomics increasingly relies on gel-free approaches or, when necessary for sample 
preparation, one-dimensional SDS-PAGE gels with subsequent in-gel digestion of proteins. In 
such workflows, quantitation is mostly performed by differential stable isotope labeling of 
proteins in the samples (e.g. tissues) that are to be compared. The introduction of the stable 
isotope label - that has the same chemical properties as its natural isotope counterpart - can be 
performed either chemically (on an isolated protein/peptide extract) or metabolically (in the 
living cell or organism). The differentially labeled samples are mixed prior to MS 
measurement, in which every peptide is then detected in form of two peptide peaks and 
relative quantitation is achieved by calculating the ratio between these signals. The stable 
isotope labeling approaches in quantitative proteomics have been extensively reviewed 
elsewhere10,11. If applicable, metabolic labeling is preferred due to the high efficiency of 
labeling and straightforward sample preparation which minimizes quantitation errors due to 
sample handling. Among several ways of metabolic labeling, stable isotope labeling by amino 
acids in cell culture (SILAC) stands out as a simple method of introducing a defined label into 
all proteins of a cell/organism12,13. This label is an amino acid, usually lysine or arginine, in 
which a defined number of 12C and/or 14N atoms are replaced with their stable (non-
radioactive) isotopes 13C or 15N, respectively. SILAC was primarily developed for cell 
culture, but is increasingly being used to label model organisms of high importance in 
physiology, such as yeast, Drosophila, C. elegans, zebrafish and even small mammals14. 
Recent application of SILAC labeling to one of the most commonly used animal models in 
physiology, the mouse, resulted in an especially promising tool for quantitative proteomics 
analysis of organs and organ substructures - Krueger et al. have used the SILAC mouse to 
address a range of physiological questions, such as protein turnover analysis in multiple 
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tissues and organs and to perform proteomic phenotyping of several knock-out mouse 
models15. Although SILAC is a method of choice for metabolic labeling, relatively high costs 
still prevent its use in other mammals and obvious ethical reasons prevent its use in humans. 
In these cases, alternative approaches, such as introducing SILAC-labeled protein extract 
from a cell line as a standard into a protein extract from a tissue, have been developed16. 
Alternatively, animals can be metabolically labeled by 15N, or protein extracts from tissues 
can be chemically labeled and quantified; isotope-coded affinity tags (ICAT)17 and tandem 
mass tags (TMT or iTRAQ)18 are the most commonly used approaches for chemical labeling 
and have already been used to analyze isolated nephron segments (see below).    
 
b. Sample preparation 
The second cornerstone of a proteomics experiment is sample preparation, which, in 
the context of this review, we will divide into organ substructure isolation and protein 
extraction. The former requires optimized protocols that depend on the anatomy of the 
analyzed organ substructure, which may vary in size, shape and accessibility; the latter 
concerns general issues of sample preparation in proteomics, such as solubility of membrane 
proteins and compatibility of lysis media with downstream sample processing (e.g. enzymatic 
digestion and MS analysis). 
 
i. Substructure isolation 
Various approaches have been used over the past ten years to isolate specific cell 
populations or subcellular structures from the kidney for transcriptome or proteome analysis. 
These approaches are often limited by either the low yield of material (i.e. using hand-
dissection of specific nephron subsegments) or by the varying degree of enrichment of cells or 
structures contaminated with other subsegments (i.e. in the case of brush border membrane 
vesicles contamined with other membranes). A problem common to all isolation techniques is 
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the control of enrichment and purity of the respective preparations. In the case of nephron 
segments, purity of segments can be tested using PCR or immunoblotting for transcripts or 
proteins with a high specificity for different subsegments. Care needs to be taken to control 
for contamination with other segments or cell types and to establish segment or cell-specific 
markers. Even though several proteins and genes are widely used as segment specific markers 
(i.e. NCC for the distal tubule, NKCC2 for the thick ascending limb, AQP2 for the collecting 
duct), several markers are much less segment specific. A similar problem is often encountered 
in preparing subcellular fractions such as brush border or basolateral membranes. Hand 
dissection of nephron segments has been performed for transcriptome analysis of human and 
rodent nephron segments2,19-21. It often requires the perfusion and incubation of the tissue with 
collagenases before dissection22,23. This approach is clearly limited by the low yield and is 
very time-consuming. A major advantage of this approach is the high purity of preparations. 
Faster isolation techniques with higher yields have been applied to proximal tubules24 and 
inner medullary collecting ducts25,26 using Percoll gradients or preparing only tissue from the 
inner medulla with a rather homogenous segment and cell population. Here the risk of 
contamination with other segments or cell populations is much higher. Transgenic mouse 
models expressing EGFP or other fluorescent proteins under the control of cell or segment-
specific promoters have become available over the last few years such as mice expressing 
EGFP in intercalated cells driven by the promoter for the B1 H+-ATPase subunit27. Kidneys 
from these mice can be used to isolate large quantitities of nephron segments or cells after 
digestion of the organ using fluorescence-guided sorting of segments or cells (COPAS: 
complex object parametric analyzer and sorter)28. The purity of these preparations depends on 
the sorting parameters, the restricted expression of the fluorescent protein and the degree of 
tissue digestion. 
Subcellular fractions have also been prepared from different nephron segments. In the 
proximal tubule, apical brush border membranes were enriched from rat cortex using the 
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traditional magnesium precipitation technique29,30. Usually enrichments of the apical brush 
border membrane are in the range of 7-15fold but they also contain luminal membranes from 
other nephron segments as well as contamination with basolateral membranes. This 
basolateral component is reflected by the fact that typical basolateral membrane proteins such 
as the Na,K-ATPase are found in the brush border membrane fraction29. Recently, Knepper 
and colleagues used a chemical approach to biotinylate basolateral membranes in vivo and 
after homogenization of the kidney basolateral isolated proteins with CaptAvidin-agarose 
beads31. Clearly, the combination of new transgenic animal models and chemical approaches 
will in future allow for purer preprations of specific protein fractions from distinct cells or 
segments at larger quantities. 
 
ii. Protein extraction 
Once an organ substructure has been isolated, it needs to be homogenized and lysed in 
a way that enables the highest possible retrieval of its proteome. Due to the chemical diversity 
and different localization of the proteins in a cell/tissue, this is not a trivial task. Ideally, 
proteins should be extracted from a tissue and solubilized in a buffer containing a potent 
denaturating agent and a detergent, digested in-solution, and the resulting peptide mixtures 
should be separated by at least two orthogonal separation methods prior to MS analysis. 
However, efficient extraction of membrane proteins requires potent ionic detergents, such as 
SDS, which complicates downstream processing of the sample as it inhibits commonly used 
proteases and is not compatible with MS. This problem is usually addressed either by running 
1D SDS-PAGE after tissue homogenization/lysis and subsequent in-gel protein digestion32; or 
by using less potent non-ionic detergents, such as N-Octylglucoside, during 
homogenization/lysis. Both approaches, however, have lower yields of proteins – especially 
membrane proteins - compared to SDS-based lysis protocols. Recently, Wisniewski et al 
introduced a sample preparation method that combines the advantages of the 1D gel-based 
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workflow (SDS compatibility) and in-solution digestion (higher peptide yields after protein 
digestion)33. The method, termed filter-aided sample preparation (FASP), involves tissue 
homogenization/lysis in an SDS-containing denaturating buffer, which is followed by 
extensive washing, buffer exchange and protein digestion on a microcentricon filter. After 
digestion, peptides are spun through the filter in an MS-compatible buffer, collected and, if 
desired, further separated. Due to straightforward sample processing, this method is 
applicable to low amounts of material, making it especially attractive for analyses of organ 
substructures and has already been applied in the analysis of the hippocampal membrane 
proteome34. 
 
c. LC-MS measurement 
After successful extraction, proteins are digested by a protease and the resulting 
peptide mixtures are mass-measured and fragmented in a mass spectrometer. Even if 
previously separated, tissue-derived protein mixtures are usually so complex that they give 
rise to thousands of peptides upon digestion. Since simultaneous ionization of such complex 
peptide mixtures would lead to a significant decrease of the measurement dynamic range, they 
are further separated by liquid chromatography (LC) prior to MS measurement. Current LC-
MS setups involve the use of nano-HPLC columns (inner diameter 25-75 µm and flow rates 
100-500 nl/min), usually packed with reverse-phase C18 material. These columns are directly 
coupled to an electrospray ionization source to minimize dead volume that may result in peak 
broadening after separation35. Such chromatographic setup results in a high peak capacity and 
resolving power, which directly affects the efficiency of the electrospray ionization and 
therefore increases the sensitivity and dynamic range of LC-MS measurement. Alternatively, 
HPLC fractions may be spotted on a target plate, mixed with a matrix and ionized using 
MALDI ionization36. An interesting development in peptide separation prior to MS is the 
introduction of the REPLAY chromatography, which is suitable for analysis of extremely low 
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amounts of material and enables performance of two consecutive and identical LC-MS 
analyses upon one sample injection, thus enabling targeted proteomics analysis and higher 
proteome coverage37. Waanders et al. have recently employed REPLAY chromatography, in 
combination with laser capture microdissection and high accuracy mass spectrometry, for 
detection of >7,000 proteins in isolated pancreatic islets38. 
Despite the extreme importance of all upstream sample processing and separation 
workflows, mass spectrometry remains the most important component of every proteomics 
experiment. There are several different MS platforms and instruments currently in routine use 
in proteomics; they have been extensively reviewed elsewhere39. Here we will roughly divide 
them into low accuracy (ion traps, triple quadrupoles) and high accuracy (quadrupole-TOF, 
FT ICR, Orbitrap) mass spectrometers. Low accuracy instruments still have high sensitivity 
and fast scan times that enable extensive proteome coverage but at the cost of resolution and 
accuracy; high accuracy instruments often have lower sensitivity and longer scan times, but 
also high dynamic range and accuracy, which increases the specificity and decreases the false 
discovery rates in protein database search. The most promising development in mass 
spectrometry is the recent introduction of fast scanning and high accuracy hybrid mass 
spectrometers, such as the new generation of quadrupole-TOFs and LTQ-Orbitrap40 mass 
spectrometers. Especially the recently developed Orbitrap Velos shows great promise for in-
depth and accurate proteome analysis by combining a fast and sensitive dual-pressure linear 
ion trap with a high accuracy Orbitrap mass analyzer. In addition, an improved higher energy 
collision-induced dissociation (HCD) collision cell enables acquisition of MS and MS/MS 
spectra at a very high mass accuracy41.     
 
d. Data processing and analysis 
An equally important segment of a proteomics experiment is MS data processing and 
protein database search. Specialized software converts the MS and MS/MS spectra into a 
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format suitable for database search. At this stage, the latest generation of processing software 
uses high measurement mass accuracy of modern mass spectrometers to identify spectral 
features important for recalibration and quantification of stable isotope pairs, if these were 
used in the experiment42. Recalibrated and quantified peak lists are then submitted to a 
database search engine, which identifies peptides by comparing measured fragmentation 
spectra with theoretical mass spectra of all peptides in a protein database, such as the 
UniProt43. Most commonly used search engines in proteomics are Mascot44, Sequest45 and 
OMSSA46. The choice of the appropriate database is of great importance: specialized 
databases, consisting of forward and reversed (or randomized) protein sequences are 
nowadays commonly used for estimation of false discovery rates of database searches, using a 
“target-decoy” approach47. Once identified, peptides are assembled into proteins. A range of 
statistics tools and bioinformatics resources, such as Gene Ontology48 or KEGG pathway 
encyclopedia49, are available for downstream analysis of large-scale proteomics datasets and 
have been reviewed elsewhere50,51. 
 
3. Global proteomics and the kidney 
Kidneys are vital organs that regulate and mediate different processes such as acid-
base and electrolyte balance, body fluid osmolality, blood pressure, elimination of metabolic 
waste products and secretion of hormones52-54. Due to its importance in body homeostasis, the 
kidney has frequently been subject to global gene expression analyses and the level of 
transcriptome and proteome and mass spectrometry-based proteomics has been extensively 
used in renal research. Current applications of renal and urinary proteomics are mainly 
directed to renal physiology and pathophysiology, especially to the identification of 
biomarkers and therapeutic targets. Consequently, current proteomic studies of the kidney 
encompass both basic research and clinical studies involving various tissue samples (e.g. 
biopsies) and urine. They differ in scope, depth and technical platform used, ranging from e.g. 
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ageing-related protein expression changes in a mouse kidney based on the 2D gel 
technology55, to the peptide-based (phospho)proteome analysis of isolated nephron segments 
or their in vitro cellular models using LC-MS/MS analysis25,26,31,43,46.  
Early global kidney proteomics studies were based on 2D gels. Sarto et al.56 detected 
more than 2000 protein spots on a single 2-D gel of the whole kidney tissue and identified 47 
proteins. More recently, kidney physiology has also been addressed at the systems level; 
Knepper and co-workers have shown how large-scale transcriptomic or proteomic data 
acquisition can be used in a specific area of molecular physiology, such as the regulation of 
the AQP2 water channel by the antidiuretic hormone vasopressin57. Modern techniques in 
protein mass spectrometry as well as “next-generation” nucleotide sequencing lead to rapid 
accumulation of data which in turn requires computational systems biology to study 
physiology at the molecular level. Similarly, proteogenomics is regarded as one of the most 
attractive approaches towards discovering biomarkers58.  
Kidney function has also been analyzed indirectly, by comparing plasma proteome to 
urinary proteome to gain insights in the mechanisms of protein filtering. Lulu et al. identified 
2611 proteins in plasma and 1522 in urine and compared them to available proteomic data, 
arriving at three groups of proteins that are handled in different ways by the kidney59. 
Proteomic studies can also be complemented by metabolomics, which is being regarded as an 
extension of proteomic analysis, e.g. in the case of acute kidney injury or in KO mouse 
tissues60,61. 
 
4. Segment-directed proteomics in the nephron/kidney 
In order to better understand physiology and pathophysiology of different organs, it is 
necessary to direct the analysis toward their functional and morphological subunits, rather 
than to the whole tissue. This approach has an additional advantage in that it simplifies the 
extracted protein mixtures and therefore facilitates detection of low-abundant gene products. 
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Furthermore, it simplifies subsequent bioinformatics analysis, e.g. the prediction of functional 
pathways. As discussed above, the isolation of the nephron segments is still largely performed 
manually, which limits the number of segments that can be handled in a short time window 
after organ harvesting. So far, there are very few proteomics studies that investigated isolated 
nephron segments. Pisitkun et al. used LC-MS of peptides from in-gel digests to identify 704 
proteins from the rat inner medullary collecting duct (IMCD) nephron segment and quantify 
changes in expression of 165 proteins in response to long-term vasopressin administration 
using chemical labeling with isotope-coded affinity tags (ICAT)26. Several studies were 
performed on the glomeruli which can be isolated to relatively high purity by a standard 
sieving method from the human62,63 and animal64 kidney and used in clinical studies and for 
biomarker discovery. Substructures of glomeruli or the component of the glomerular filtration 
barrier, i.e. podocytes, mostly originating from the cell culture have also been investigated65. 
Mesangial cells were also investigated, either from rat66, or human67. Many proteomic 
investigations focused on nephron physiology in cell culture models or brush-border 
membrane (BBM) vesicles29. There are attempts to analyze the membrane proteome of 
polarized epithelial cells and to provide a data set of the most abundant proteins present in 
renal proximal tubule cell membranes. Besides the study of Cutillas et al.29 (discussed above), 
there is another report on the analysis of basolateral vs apical membrane in the rat IMCDs 31. 
In that study, biotinylation and streptavidin affinity chromatography were used to label and 
enrich proteins from apical and basolateral membranes of rat kidney inner medullary 
collecting ducts (IMCDs) prior to LC-MS/MS. That study identified 222 integral and GPI-
linked membrane proteins.  
In addition to whole cells and cell membranes, different organelles were also subject 
to proteomics analysis, like the mouse kidney peroxisomes. Wiese et al. used classical 
subcellular fractionation in combination with MS-based proteomics to confirm most of the 
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known and identify 15 new peroxisomal candidates, thus assembling an in-depth protein 
catalogue of mammalian peroxisomes68.  
Except IMCD and glomeruli, to our knowledge no other isolated nephron segment was 
so far analyzed on the proteome level. However, global and segment-specific gene expression 
in the nephron has been addressed at the transcriptome level. Chabardes-Garonne et al. 
isolated the glomerulus and seven different nephron segments by microdissection from human 
kidney and characterized their transcriptome using the serial analysis of gene expression 
(SAGE), resulting in data for the segment specific expression of more than 600 genes2. Given 
the recent developments in the field in mass spectrometry proteomics, global and segment-
specific studies of gene expression at the proteome level are within reach. 
 
5. Structure-specific proteomics in other tissues 
The kidney is not the only complex organ of which isolated substructures have been 
analyzed. Other examples are intestine, brain and pancreas. The colon epithelium is protected 
from the luminal microbes by an inner firmly attached mucus layer and an outer loose mucus 
layer, which were analyzed to better understand their protein composition69. Analyses were 
also performed on subcellular structures allowing detailed proteome analysis and 
corresponding functional characteristics of a specific organelle. Wong et al. studied 
microsomal organelles including the ER, Golgi, and prechylomicron transport vesicle 
(PCTV)70. Microsomes from primary hepatocytes and enterocytes from rodent liver and 
intestinal tissue were analyzed, and profiled with a combination of two-dimensional gel 
electrophoresis and mass spectrometry.  
In the pancreas, Waanders et al38 performed quantitative proteomic analysis of a single 
microdissected pancreatic islets and kidney glomeruli isolated by laser capture, demonstrating  
the sensitivity of state-of-the-art methods, and reported a list of a 7014 pancreatic islets 
proteins. Investigations have also been done toward a better understanding of beta-cells and 
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insulinoma cells in different conditions, in order to elucidate the mechanisms regulating 
insulin secretion and the development of various forms of diabetes, as well as to identify drug 
targets for therapeutic approaches71. As summarized in a recent review by Brunner et al72, 
there are several proteomic studies on effects of glucotoxicity in pancreas, pancreatic islets 
and β-cells. In addition, Farina et al73 reported on a proteomic analysis of a human bile and its 
potential application for cancer diagnosis.   
The brain is another complex organ requiring investigation on a substructure level. 
Proteomics studies range from those where a proteome of an organelle is analyzed in different 
brain regions with a pharmacological aspect74, to those comparing human and animal (mouse) 
material75. Investigations of isolated brain regions are applied to diseases like schizophrenia, 
Parkinson's disease, epilepsy, and bipolar disorder which have been associated with the 
thalamus76. Also in neurophysiology and neuropathology, studies are being performed in 
which specific subcellular compartments are investigated, resulting in e.g. mapping of the 
mouse brain cytosolic phosphoproteome77. Given its central importance, brain proteomics is a 
subject of intense research of scientific consortia, such as the Human Proteome Organization 
(HUPO) Brain Proteome Project78. 
 
6. Application of proteomics to normal and diseased kidney function 
Proteomics technology has been applied to study different aspects of normal kidney 
function, kidney function in genetically modified animals as well as disease processes in 
humans and various animal models of kidney diseases. The majority of studies focused on 
searching for markers of disease either in blood/serum or in urine. The obvious advantage of 
this approach is the simple and non-invasive access to these body fluids and the promise to 
uncover markers of early disease, its progression, prognosis, and the success of treatment. 
This field of biomarker research has rapidly grown with the technical advancements. Adachi 
et al. have used high accuracy MS to detect more than 1500 proteins in human urine, 
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including a large proportion of membrane proteins, making urine indeed an interesting body 
fluid for biomarker research79. Similarly, Knepper and colleagues detected nearly 1100 
proteins in human urinary exosomes and also determined phosphorylation sites80. Major 
achievements of urine proteomics have been reviewed elsewhere3,4,81. Clearly, major 
limitations in this field are that potential markers still require validation and that panels of 
markers rather than single markers may be needed for diagnosis and monitoring of disease 
progression. Unfortunately, little progress has been made in using urine proteomics to identify 
physiological or pathophysiological processes underlying disease development and 
progression. The problem here is that it is often unknown from where along the nephron 
certain proteins originate and if and how their appearance in urine correlates with their 
abundance and involvement in cellular processes.  
Using kidney tissue, the most detailed studies using proteomics to examine physiological 
processes focused on the mechanisms of regulated water absorption and urine concentration 
along the inner medullary collecting duct (reviewed in:  Hoffert et al.57; Hoorn et al.82; 
Pisitkun et al.83). These studies identified various novel proteins involved in the regulation of 
the AQP2 water channel and detected phosphoproteins and phosphorylation sites in the 
channel and associated proteins. Furthermore, transcription factors were discovered that may 
play a role in the cell-specific expression of AQP284. Importantly, these studies were carried 
out with relatively pure starting material from the isolated and enriched inner medullary 
collecting duct allowing predicting regulatory pathways. Moreover, many of these studies 
were not limited to the descriptive listing of proteins but tested also the functional relevance 
of some predicted pathways and phosphorylation sites. 
Only few other studies went through the process of purifiying specific cells or nephron 
segments for the subsequent proteomic analysis24,62,85-87. Some have addressed changes in 
protein abundance or appearance in cells or tissue from human healthy and diseased kidneys. 
Schordan et al. observed changes in cytoskeletal proteins in cultured human podocytes under 
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high glucose conditions and found similar changes in biopsies from patients with diabetic 
nephropathy65. Recently, we performed a proteome analysis of early and late proximal tubules 
prepared by hand-dissection from control animals and acidotic mice and assessed changes in 
protein expression by adding kidney tissue from SILAC mice (Velic, Macek, Nowik, Mann, 
Wagner, unpublished results). We could detect more than 300 altered proteins from a total of 
more than 2000 proteins and could confirm alterations by immunoblotting isolated proximal 
tubules. Moreover, using similar material we also performed transcriptome analysis for 
mRNA and miRNA changes allowing now to integrate different data sets for the same 
treatment and nephron segments (Nowik, Lindenmeyer, Cohen, Wagner, unpublished results). 
Interestingly, many changes on mRNA level do not translate onto the protein level and vice 
versa. Preliminary analysis confirms known pathways such as ammoniagenesis to be 
regulated but suggests also the involvement of other processes such as remodeling of the 
cytoskeleton requiring further functional experiments. Many more studies used cell lines 
derived from various nephron regions with the major limitation that it remains unclear how 
far these cell lines reflect the in-vivo situation88. Most studies have applied proteomics to 
study disease processes using whole kidney tissue as material55,89-94. Obviously, this approach 
is simple and fast but has major limitations due to the morphological diversity and complexity 
of the kidney. Thus, using whole kidney material it appears impossible to deduce pathways 
since it remains unknown which cells expressed the proteins of interest and if several 
regulated proteins occurred in the same cells.  It may therefore not come as a surprise that this 
approach has not yielded many more insights into fundamental (patho)physiological 
processes. 
 
7. Outlook 
At least fourmajor challenges for proteomics in the field of kidney research remain: 1) 
further refinement of tools, 2) integration of data from various levels of “-omics” 
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measurements, 3) test the functional relevance of observed changes in “-omics” 
measurements, and 4) asking the right questions that allow a return to hypothesis-driven 
research based on clues coming from proteome measurements. 
The application of proteomics to study kidney structure, function, diseases and to develop 
disease markers will advance rapidly in the next years with the further refinement and 
application of new and highly sensitive methods for sample preparation and high accuracy 
MS measurement discussed here, and with the ability to separate functional/morphological 
units from kidney tissue. The latter point has become feasible in mice with the generation of 
transgenic mouse lines expressing selection markers in specific cells. It is more challenging in 
native tissue, particularly in human tissue, where other approaches may need further 
development. The preparation of pure glomerular protein from biopsies has been achieved, 
but laser capture of other nephron segments or cells in combination with very sensitive 
detection methods may provide a solution to isolation of nephron subsegments from human 
material. 
A second challenge comes from the necessity to integrate data from different levels of “-
omics” measurements such as transcriptome (miRNA, mRNA), proteome, phosphoproteome, 
or metabolome experiments. This type of analysis creates sets of data of enormous complexity 
and ambiguity. Proteins and metabolites are often linked to more than one pathway or are 
even not known yet to take part in specific pathways. With the ability to screen more and 
more posttranslational protein modifications, the complexity will even further increase. 
Again, the purity and homogeneity of the starting material will be crucial to perform 
meaningful pathway analyses.  
Inevitably, a third and fourth challenge arises from the complexity and ambiguity of data sets 
coming from such multi-layered experiments. In most cases, proteome measurements have 
represented the end-point of experiments. With the refinement of preparing the starting 
samples and more sensitive measurements it will be possible to better predict regulated 
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pathways and functions. However, ultimately, these predictions will require functional and 
experimental proof returning to the paradigm of hypothesis-driven research. The importance 
and difficulty of these last two points must not be underestimated, but it will ultimately bring 
sense to the data generated by high-throughput screening methodologies.  
Taken together proteomics of the nephron subsegments or ther specific kidney cell 
types, as well as the proteomics of urine, will in future provide a high throughput method in 
renal physiology and pathophysiology. This approach will also be used to elucidate protein-
signaling events, identifying the proteins involved as well as the modifications of these 
proteins. Together with functional experiments, this will lead towards a better understanding 
of renal diseases and the discovery of biomarkers that will improve diagnosis and treatment of 
renal diseases.  
 
 
 
 
 
 
 
 
Figure legends 
 
Figure 1 
Schematic diagram of the major subsegments of the nephron indicating morphologically and 
functionally distinct regions. Of note, further distinctions can be made i.e. based on the 
localization of the glomerulum (subcortical or juxtamedullary), or the length of the loop of 
Henle. Figure modified after Kriz et al (1). 
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Figure 2 
Workflow of proteomic experiments starting from the dissection of the structures of choice 
(i.e. specific kidney cells), protein extraction, separation by 1D gels, measurements by mass 
spectrometry, and subsequent peptide and protein identification.
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